← CVS HEALTH Corp CVS
Market Price
$97.17
Market Cap
$121.19B
P/E Ratio
69.91
Revenue (FY 2025)
↑7.8% YoY
$402.07B
3-Yr CAGR: 7.6%
Net Income
↓-61.7% YoY
$1.77B
Net Margin: 0.4%
Free Cash Flow
↑23.4% YoY
$7.81B
FCF Yield: 6.44%
EPS (Diluted)
↓-62.0% YoY
$1.39
Basic: $1.40
Return on Equity
Efficiency
2.4%
ROA: 0.7%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (CVS)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $177,526.0M | — | $28,857.0M | $5,317.0M | — | $4.90 | — | $10,069.0M | $7,845.0M | — |
| FY 2017 | $184,765.0M | +4.1% | $28,545.0M | $6,622.0M | +24.5% | $6.44 | +31.4% | $8,007.0M | $6,089.0M | -22.4% |
| FY 2018 | $193,919.0M | +5.0% | $37,472.0M | $-594.0M | -109.0% | $-0.57 | -108.9% | $8,865.0M | $6,828.0M | +12.1% |
| FY 2019 | $256,776.0M | +32.4% | $98,057.0M | $6,634.0M | +1,216.8% | $5.08 | +991.2% | $12,848.0M | $10,391.0M | +52.2% |
| FY 2020 | $268,706.0M | +4.6% | $104,725.0M | $7,179.0M | +8.2% | $5.46 | +7.5% | $15,865.0M | $13,428.0M | +29.2% |
| FY 2021 | $292,111.0M | +8.7% | $116,308.0M | $7,910.0M | +10.2% | $5.95 | +9.0% | $18,265.0M | $15,745.0M | +17.3% |
| FY 2022 | $322,467.0M | +10.4% | $125,575.0M | $4,149.0M | -47.5% | $3.14 | -47.2% | $16,177.0M | $13,450.0M | -14.6% |
| FY 2023 | $357,776.0M | +10.9% | $140,678.0M | $8,344.0M | +101.1% | $6.47 | +106.1% | $13,426.0M | $10,395.0M | -22.7% |
| FY 2024 | $372,809.0M | +4.2% | $166,522.0M | $4,614.0M | -44.7% | $3.66 | -43.4% | $9,107.0M | $6,326.0M | -39.1% |
| FY 2025 | $402,067.0M | +7.8% | $180,900.0M | $1,768.0M | -61.7% | $1.39 | -62.0% | $10,639.0M | $7,807.0M | +23.4% |
Valuation
Market Price
$97.17
Market Cap
$121.19B
Enterprise Value
$177.30B
P/E Ratio
69.91
P/B Ratio
1.65
FCF Yield
6.44%
Dividend Yield
2.74%
Shares Outstanding
Profitability & Margins
Gross Margin
44.99%
Operating Margin
1.16%
Net Margin
0.44%
Return on Equity (ROE)
2.35%
Return on Assets (ROA)
0.70%
Asset Turnover
1.59x
Revenue 3-Yr CAGR
7.63%
Financial Health & Liquidity
Current Ratio
3.34
Cash Ratio
0.38
Debt / Equity
0.858
Debt / Assets
0.255
Cash & Equivalents
$8.45B
Total Debt
$64.57B
Book Value / Share
$58.95
Cash Flow Efficiency
Operating Cash Flow
$10.64B
Capital Expenditures (CapEx)
$2.83B
Free Cash Flow
$7.81B
OCF / Revenue
2.65%
FCF / Revenue
1.94%
FCF 3-Yr CAGR
-16.58%
Per Share Metrics
EPS (Diluted)
$1.39
EPS (Basic)
$1.40
Dividends / Share
$2.66
Book Value / Share
$58.95
EPS YoY Growth
-62.02%
Balance Sheet (FY 2025)
Total Assets
$253.54B
Total Liabilities
$178.16B
Stockholders' Equity
$75.21B
Current Assets
$74.71B
Current Liabilities
$22.39B